OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Role of Stellate Cells in Pancreatic Ductal Adenocarcinoma: Targeting Perspectives
Yang Wu, Chun Zhang, Kuirong Jiang, et al.
Frontiers in Oncology (2021) Vol. 10
Open Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

Cancer‐associated fibroblasts: Key players in shaping the tumor immune microenvironment
Mélanie Desbois, Yulei Wang
Immunological Reviews (2021) Vol. 302, Iss. 1, pp. 241-258
Closed Access | Times Cited: 137

The Tumor Microenvironment in Tumorigenesis and Therapy Resistance Revisited
Kevin Dzobo, Dimakatso Alice Senthebane, Collet Dandara
Cancers (2023) Vol. 15, Iss. 2, pp. 376-376
Open Access | Times Cited: 94

Cellular and molecular mechanisms of perineural invasion of pancreatic ductal adenocarcinoma
Jingbo Li, Rui Kang, Daolin Tang
Cancer Communications (2021) Vol. 41, Iss. 8, pp. 642-660
Open Access | Times Cited: 66

The Immune Landscape of Human Pancreatic Ductal Carcinoma: Key Players, Clinical Implications, and Challenges
Marie Müller, Vincent Haghnejad, Marion Schaefer, et al.
Cancers (2022) Vol. 14, Iss. 4, pp. 995-995
Open Access | Times Cited: 48

Nanoparticle-based therapeutic strategies targeting major clinical challenges in pancreatic cancer treatment
Mubin Tarannum, Juan L. Vivero‐Escoto
Advanced Drug Delivery Reviews (2022) Vol. 187, pp. 114357-114357
Open Access | Times Cited: 40

PDAC, the Influencer Cancer: Cross-Talk with Tumor Microenvironment and Connected Potential Therapy Strategies
Leonardo Mercanti, Maria Sindaco, Mariangela Mazzone, et al.
Cancers (2023) Vol. 15, Iss. 11, pp. 2923-2923
Open Access | Times Cited: 22

Recent advances in drug delivery and targeting for the treatment of pancreatic cancer
Nilkamal Pramanik, Aditya K. Gupta, Yashwardhan Ghanwatkar, et al.
Journal of Controlled Release (2024) Vol. 366, pp. 231-260
Closed Access | Times Cited: 13

Pancreatic Ductal Adenocarcinoma: Molecular Pathology and Predictive Biomarkers
Mehran Taherian, Hua Wang, Huamin Wang
Cells (2022) Vol. 11, Iss. 19, pp. 3068-3068
Open Access | Times Cited: 28

Cellular collusion: cracking the code of immunosuppression and chemo resistance in PDAC
Chiara Musiu, Francesca Lupo, Antonio De Agostini, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6

Role of the Tumor Microenvironment in Regulating Pancreatic Cancer Therapy Resistance
Daiyong Deng, Riya Patel, Cheng-Yao Chiang, et al.
Cells (2022) Vol. 11, Iss. 19, pp. 2952-2952
Open Access | Times Cited: 27

Cellular metabolism in pancreatic cancer as a tool for prognosis and treatment (Review)
Michal Zuzčák, Ján Trnka
International Journal of Oncology (2022) Vol. 61, Iss. 2
Open Access | Times Cited: 25

Clinical Significance of Tumor-Infiltrating Conventional and Plasmacytoid Dendritic Cells in Pancreatic Ductal Adenocarcinoma
Ioana Plesca, Iva Benešová, Carolin Beer, et al.
Cancers (2022) Vol. 14, Iss. 5, pp. 1216-1216
Open Access | Times Cited: 23

Biodistribution and therapeutic efficacy of a gold nanoparticle-based targeted drug delivery system against pancreatic cancer
Chandra Kumar Elechalawar, Suresh Kumar Gulla, Ram Vinod Roy, et al.
Cancer Letters (2024) Vol. 589, pp. 216810-216810
Closed Access | Times Cited: 5

Targeting Neoantigens in Pancreatic Ductal Adenocarcinoma
Gurkaranjot Singh, Drew Kutcher, Rajeshwar Lally, et al.
Cancers (2024) Vol. 16, Iss. 11, pp. 2101-2101
Open Access | Times Cited: 5

Cold Atmospheric Plasma Does Not Affect Stellate Cells Phenotype in Pancreatic Cancer Tissue in Ovo
Angela Privat‐Maldonado, Ruben Verloy, Edgar Cardenas Delahoz, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 4, pp. 1954-1954
Open Access | Times Cited: 20

Microphysiological systems as models for immunologically ‘cold’ tumors
Daniela Gaebler, Stephanie J. Hachey, Christopher C.W. Hughes
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 4

Multiplexed Imaging Mass Cytometry Analysis Characterizes the Vascular Niche in Pancreatic Cancer
Jonathan H. Sussman, Nathalia Kim, Samantha B. Kemp, et al.
Cancer Research (2024) Vol. 84, Iss. 14, pp. 2364-2376
Closed Access | Times Cited: 4

Unraveling the molecular architecture of autoimmune thyroid diseases at spatial resolution
Rebeca Martínez‐Hernández, Nuria Sánchez de la Blanca, Pablo Sacristán-Gómez, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4

The P2X7 Receptor Stimulates IL-6 Release from Pancreatic Stellate Cells and Tocilizumab Prevents Activation of STAT3 in Pancreatic Cancer Cells
Lara Magni, Rayhana Bouazzi, Hugo Heredero Olmedilla, et al.
Cells (2021) Vol. 10, Iss. 8, pp. 1928-1928
Open Access | Times Cited: 24

Senescent Human Pancreatic Stellate Cells Secrete CXCR2 Agonist CXCLs to Promote Proliferation and Migration of Human Pancreatic Cancer AsPC-1 and MIAPaCa-2 Cell Lines
Tetsuya Takikawa, Shin Hamada, Ryotaro Matsumoto, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 9275-9275
Open Access | Times Cited: 14

Notch signaling pathway in pancreatic tumorigenesis
Wen-Cheng Chung, Keli Xu
Advances in cancer research (2023), pp. 1-36
Closed Access | Times Cited: 8

Page 1 - Next Page

Scroll to top